Vienna, Austria

Rudolph Valenta

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 2 EPO patents. Top assignee: Mead Johnson Nutrition Company. Active years: 2014.


 

 

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Rudolph Valenta

Introduction

Rudolph Valenta is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of allergen identification, particularly in relation to milk proteins. His innovative methods have the potential to improve the lives of individuals with milk allergies.

Latest Patents

Valenta holds a patent for a method for identifying allergenic proteins and peptides. This method specifically focuses on identifying allergenic milk proteins and/or peptides. The process involves providing an expression library derived from the mammary gland tissue of a lactating cow, expressing proteins or peptides from this library, and determining their binding capacity to IgE from the serum of individuals sensitive to cow's milk. The identification of allergenic proteins is further confirmed through interactions with basophil cells, eosinophil cells, or mast cells.

Career Highlights

Throughout his career, Rudolph Valenta has worked with prominent companies such as Mead Johnson Nutrition Company and Mjn U.S. Holdings LLC. His work in these organizations has allowed him to apply his expertise in allergen research and contribute to advancements in nutritional science.

Collaborations

Valenta has collaborated with notable colleagues, including Ric Van Tol and Heidrun Hochwallner. These partnerships have facilitated the exchange of ideas and fostered innovation in the field of allergen identification.

Conclusion

Rudolph Valenta's contributions to the identification of allergenic proteins and peptides highlight his role as an influential inventor in the field of allergen research. His innovative methods and collaborations continue to pave the way for advancements that can benefit individuals with allergies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…